Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of two vaccines administered concomitantly. Cervarix is a Human Papillomavirus Vaccine that protects against HPV types 16 and 18, which are responsible for cervical cancer. Menveo is a Meningococcal Conjugate Vaccine that provides protection against Neisseria meningitidis serogroups A, C, Y, and W-135, which cause invasive meningococcal disease. Clinical data supports that these vaccines can be administered together without clinically relevant interference with antibody response to either vaccine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cervarix + menveo.